WHO ranked Singapore's health system, the sixth most effective system in the world and the best in Asia in 2000.
Healthcare Sector in Singapore
Singapore’s medical standards are among the highest in Asia and it is widely acknowledged as a regional
centre for medical excellence.
WHO ranked it the sixth most effective system in the world and the best in Asia in 2000.
Singapore has the second lowest infant mortality in the world and the ninth highest life
expectancy (Lancet). Its quality of healthcare, especially in high end specialities and surgical
procedures, continue to attract medical travellers from South East Asia, North Asia and Europe,
towards its target of 1 million by 2012.Private hospitals which had double digit growth in
international patients in 2011, continue to expand with new hospitals and medical centres.
Singapore’s clinicians are viewed as Key Opinion Leaders in South East Asia, and are encourged
to undertake more research to spur the Government’s translational medicine efforts.
The government encourages personal responsibility through a system of co-payment for
healthcare services. Healthcare spend is 3.7% of the GDP, which is set to rise with the growth in
ageing population. A quarter of Singaporeans will be over 65 years by 2030. The aim is to
continue to provide quality medical care, while maintaining costs and Singapore’s edge as the
leading provider of high technology medicine in the region.
Singapore’s Biomedical Sciences (BMS) sector, jointly driven by the Agency of Science,
Technology and Research, Economic Development Board and the Ministry of Health, has had
consideratble investment since 2000. It continues to expand, with activities ranging across R&D,
clinical trials, and commercialisation, supported by high level of IP protection and industry
standards. The BMS Industry Partnership Office serves as a single point of contact for industry
to carry out R&D projects requiring the capabilities of multiple Singapore agencies, such as
research institutes and hospitals.
The Healthcare 2020 Masterplan has three strategic objectives – enhancing accessibility, quality
and affordability of healthcare for Singaporeans, to be achieved by:
ξ Expansion of healthcare infrastructure – with two new general hospitals and four new
community hospitals, resulting in additional 3,700 hospitals beds: 1,900 acute hospital
beds and 1,800 community hospital beds, by 2020.
ξ Expansion of primary specialist outpatient capacity by 2013. In addition, new private
medical centres are under development.
Other ongoing initiatives include:
ξ Upgrading of primary care
ξ Strengthening Intermediate and Long Term Care (ILTC) infrastructure
ξ Enhancing mental health infrastructure
ξ Healthcare training and professional development
ξ National Electronic Healthcare Records system
ξ Research and public healthcare initiatives
ξ Third medical school, a jv with Imperial College
Under Budget 2012, around £2.35 billion was allocated for healthcare expenditure, a rise of
17.8% over 2011. Annual healthcare expenditure is expected to double to £4 billion over the next
5 years as the government boosts capacity in the public sector and makes long term care
£250 million is set aside to develop comprehensive community care infrastructure for the elderly
by 2016. This will comprise
100 facilities including 10 nursing homes and senior care and activity centres across the island,
MOH plans to have another 20-25 nursing homes with 6,600 beds by 2020.
The private sector, with 30-40% of its patient base from overseas, is also enhancing capabilities
to strengthen Singapore’s medical
ξ offer.. Two new hospitals opened in 2012, with another slated for 2013, and £50 million
expansion by another.Use bullet points to emphasise
Latest export opportunities – Healthcare & Medical
Latest export opportunities – Singapore
Getting into the market
All medical devices must be registered with the Health Sciences Authority of Singapore:
www.hsa.gov.sg, before trial or sale. Public procurement is undertaken through
www.gebiz.gov.sg, as well as through group purchasing by the public healthcare clusters for the
most commonly used items for government hospitals. Individual hospitals also purchase directly.
As technical support and after sales service is vital, UK companies are advised to work through
distributors to address the wide ranging opportunities. Singapore companies also have links to
the wider South East Asian region, and can access those markets for UK companies.
More about doing business in Singapore
Market intelligence is critical when doing business overseas, and UKTI can provide bespoke
market research and support during overseas visits though our chargeable Overseas Market
Introduction Service (OMIS).
To commission research or for general advice about the market, get in touch with our specialists
in country - or contact your local international trade team.
ξ Valsa Panicker, British High Commission Singapore
Tel: +65 64244 311 or Email: Valsa.Panicker@fco.gov.uk
ξ Amanda Leong, British High Commission Singapore
Tel: +65 64244 307 or Email: Amanda.Leong@fco.gov.uk
Contact your local international trade team
UKTI runs a range of events for exporters, including seminars in the UK, trade missions to
overseas markets and support for attendance at overseas trade shows.
Medical Fair Asia
Date: 12 – 14 September 2012
Medical Manufacturing Asia
Date: 12 -14 September 2012
Date: 2 – 4 April 2014
Latest events – Healthcare & Medical
More about OMIS and other UKTI services for exporters